Component

Mouse acyl-CoA synthetase short-chain family member 2 / Acss2

Species, exposure, manipulation and evidence limits are specified on each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Silencing hepatic Acss2 suppressed conversion of bolus fructose carbon into hepatic acetyl-CoA and fatty acids in mice.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    dose
    Bolus 2 g/kg labeled fructose plus 2 g/kg glucose; interventions specified by claim
    duration
    Acute isotope sampling up to 6 h
    evidence_access
    Primary full-text methods/results and metadata inspected.
    evidence_scope
    literature_reviewed; source-specific curation
    experimental_model
    Wild-type mice, microbiota depletion and liver Acss2-silencing experiments
    exposure_scope
    Component mixture
    limitations
    Carbon tracing supports microbial acetate supply; antibiotic depletion is not a clinical recommendation and microbiota effects are not universal across diets.
    nutrient_topic
    HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
    organism
    Wild-type mice, microbiota depletion and liver Acss2-silencing experiments
    plain_language
    Silencing hepatic Acss2 suppressed conversion of bolus fructose carbon into hepatic acetyl-CoA and fatty acids in mice.
    primary_references
    Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. (2020). https://pubmed.ncbi.nlm.nih.gov/32214246/ DOI: 10.1038/s41586-020-2101-7
    route
    Oral gavage and experimental microbiota/gene perturbation
    tissue
    Portal acetate and hepatic fatty-acid labeling
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 221–231

    Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Wild-type mice, microbiota depletion and liver Acss2-silencing experiments · source_derived_draft · unverified_draft

    ## hfcs-acss2-silencing Silencing hepatic Acss2 suppressed conversion of bolus fructose carbon into hepatic acetyl-CoA and fatty acids in mice. Model/species: Wild-type mice, microbiota depletion and liver Acss2-silencing experiments Tissue: Portal acetate and hepatic fatty-acid labeling Exposure: Bolus 2 g/kg labeled fructose plus 2 g/kg glucose; interventions specified by claim Route: Oral gavage and experimental microbiota/gene perturbation Duration: Acute isotope sampling up to 6 h Exposure scope: Component mixture Limits: Carbon tracing supports microbial acetate supply; antibiotic depletion is not a clinical recommendation and microbiota effects are not universal across diets. Reference: Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. (2020). https://pubmed.ncbi.nlm.nih.gov/32214246/ DOI: 10.1038/s41586-020-2101-7 Access: Primary full-text methods/results and metadata inspected.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards